1. Home
  2. PSN vs GRFS Comparison

PSN vs GRFS Comparison

Compare PSN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

N/A

Current Price

$51.95

Market Cap

5.2B

Sector

Technology

ML Signal

N/A

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$8.21

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PSN
GRFS
Founded
1944
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.2B
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
PSN
GRFS
Price
$51.95
$8.21
Analyst Decision
Buy
Buy
Analyst Count
14
2
Target Price
★ $61.36
$10.37
AVG Volume (30 Days)
★ 1.0M
699.5K
Earning Date
10-28-2026
07-28-2022
Dividend Yield
N/A
★ 3.24%
EPS Growth
★ 3.77
N/A
EPS
★ 0.85
N/A
Revenue
★ $6,364,245,000.00
N/A
Revenue This Year
$0.14
$2.18
Revenue Next Year
$4.75
$6.15
P/E Ratio
$60.22
★ $18.67
Revenue Growth
N/A
★ N/A
52 Week Low
$36.26
$6.96
52 Week High
$86.70
$9.77

Technical Indicators

Market Signals
Indicator
PSN
GRFS
Relative Strength Index (RSI) 59.88 48.74
Support Level $47.04 $7.52
Resistance Level $53.25 $8.29
Average True Range (ATR) 2.10 0.24
MACD -0.10 -0.05
Stochastic Oscillator 68.22 0.54

Price Performance

Historical Comparison
PSN
GRFS

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: